John Bishop Email Address

Chairman and Chief Executive Officer

Cepheid (Nasdaq: CPHD) is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use molecular systems and tests. The advantages over other technologies are accuracy, speed, and ease-of-use -- quickly getting important information into the hands of healthcare professionals to dramatically improve patient outcomes.

Mr. Bishop joined Cepheid as Chief Executive Officer and as a director in April 2002, and became Chairman of the Board of Directors in February 2013. From 1993 to 2002, Mr. Bishop served as President, later President and Chief Executive Officer, and a director of Vysis, Inc., a genomic disease management company that was acquired by Abbott. From 1991 until 1993, Mr. Bishop was Chairman and Chief Executive Officer of MicroProbe Corporation, a biotechnology company, and, from 1987 until 1991, of Source Scientific Systems, a biomedical instrument manufacturing company. Prior to that, from 1984 to 1986, Mr. Bishop was President and Chief Operating Officer of Gen-Probe, Inc. Before joining Gen-Probe, Mr. Bishop held various management positions between 1968 and 1984 at American Hospital Supply Company and its affiliates, including a three-year assignment in Japan as Executive Vice President and Chief Executive Officer of International Reagents Corp., a joint venture between American Hospital Supply Company and Green Cross Corporation. Mr. Bishop served as a director of Conceptus from February 2009 until June 2013 when it was acquired by the Bayer Group. He has been a member of the AdvaMed Dx Board, since 2010, and was elected Chairman in December 2013. In 2011, Mr. Bishop received the Ernst & Young Entrepreneur Of The Year® Northern California Award in the Life Sciences category.